Effects of eculizumab and rituximab on visual function, motor function and social quality in patients with NMOSD: a comparative study
NMOSD significantly impairs visual, motor, and social functions. Eculizumab demonstrated superior efficacy over rituximab in improving functional outcomes and quality of life, supporting its role as an effective therapeutic option for NMOSD.
Authors
- Xiangzeng Kong (ORCID: https://orcid.org/0000-0001-8492-1349)
- Meng Li (ORCID: https://orcid.org/0000-0001-9494-4552)
- Xiaoman Zhang (ORCID: https://orcid.org/0000-0003-4821-203X)
- Jiyuan Li (ORCID: https://orcid.org/0000-0002-5479-0912)
- Xiao Wang (ORCID: https://orcid.org/0000-0002-7748-5670)
- Yongzhi Zhang (ORCID: https://orcid.org/0000-0003-4047-5345)
- Yihan Liu (ORCID: https://orcid.org/0009-0007-6721-0204)
Institutions
- Hebei Medical University (CN)
- Shanxi Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
- First Hospital of Shanxi Medical University (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.3389/fneur.2025.1698950
- Primary Topic
- Hereditary Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Hebei Province